Shopping Cart
Remove All
Your shopping cart is currently empty
Muzastotug (ADG126) is a humanized monoclonal antibody targeting CTLA-4/CD152 that selectively inhibits CTLA-4-mediated regulatory T cells (Tregs) in the tumor microenvironment, demonstrating anti-tumor immunotherapy efficacy.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $163 | - | In Stock | |
| 5 mg | $463 | - | In Stock | |
| 10 mg | $745 | - | In Stock | |
| 25 mg | $1,120 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock |
| Description | Muzastotug (ADG126) is a humanized monoclonal antibody targeting CTLA-4/CD152 that selectively inhibits CTLA-4-mediated regulatory T cells (Tregs) in the tumor microenvironment, demonstrating anti-tumor immunotherapy efficacy. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CTLA-4 |
| Cas No. | 2750031-18-4 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.